1-833-ZEPOSIA

ZEPOSIA is a once-daily pill for adults with relapsing multiple sclerosis (MS).

Take as directed by your doctor if certain liver problems exist.

MenuClose

ZEPOSIA is a once-daily pill for adults with relapsing multiple sclerosis (MS).

Take as directed by your doctor if certain liver problems exist.

Co-pay savings and other financial support

Depending on your insurance coverage and financial need, there may be several different ways to save on the cost of ZEPOSIA and the tests needed before treatment. Our Support Coordinators can help you understand your options.

ZEPOSIA® Co-pay Program icon

Pay as little as $0 a month for ZEPOSIA

If you have private or commercial insurance, you may be eligible to pay as little as $0 a month for your ZEPOSIA prescription. Additional eligibility requirements and terms & conditions apply. Please click here for more information.

Enroll now

Other ways to save

Insurance form icon

Get ZEPOSIA while you wait for insurance approval*

If you have private or commercial insurance and are experiencing delays or issues with coverage, the ZEPOSIA Bridge Program may be able to provide ZEPOSIA to you, as needed (for up to 24 months).

Dollar sign icon

Reimbursement for certain medical costs

Any potential out-of-pocket costs may be reimbursed. There may be costs associated with some of the routine medical tests, but depending on where these tests take place, eligible, commercially insured patients may qualify for reimbursement. Additional eligibility requirements and terms & conditions apply. Please click here for more information.

ZEPOSIA® 360 Support - support coordinator icon

Have questions about financial assistance or out-of-pocket costs?

Contact a Support Coordinator at 1-833-ZEPOSIA (1-833-937-6742), Monday to Friday, 8 AM – 8 PM ET.

  • While Support Coordinators can answer questions about ZEPOSIA 360 SupportTM, they cannot provide medical advice.
  • The Bridge Program is available at no cost for eligible, commercially insured, on-label diagnosed patients if there is a delay in determining whether commercial prescription coverage is available, and is not contingent on any purchase requirement, for up to 24 months (dispensed in 30-day increments). The Bridge Program is not available to patients who have prescription insurance coverage through a state or federal healthcare program, including but not limited to Medicare, Medicaid, Medigap, CHAMPUS, TRICARE, Veterans Affairs (VA), or Department of Defense (DoD) programs and is available for no more than 12 months to patients in MA, MN, and RI. Appeal of any prior authorization denial must be made within 90 days or as per payer guidelines, to remain in the program. Eligibility will be re-verified in January for patients continuing into the following year, and may be at other times during program participation. Offer is not health insurance. Once coverage is approved by the patient’s commercial insurance plan, the patient will no longer be eligible. Void where prohibited by law, taxed, or restricted. Bristol-Myers Squibb Company reserves the right to rescind, revoke, or amend this program at any time without notice. Other limitations may apply.